Quintrio
Home

PHARMACEUTICAL PREPARATIONS

Talphera, Inc. Common Stock

TLPH

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Last trade $0.82
Day change -$0.0409 (-4.75%)
Day range $0.81 – $0.885
Volume 66,861
Market cap $45M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$44.68M
Price / earnings
—
Price / book
4.17×
Price / sales
—
EV / sales
—
EV / EBITDA
-2.2×

Profitability

Earnings per share
-$0.28
Return on assets
-62.18%
Return on equity
-136.84%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0×
Current ratio
1.41×
Quick ratio
1.41×
Cash ratio
1.02×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$12.79M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for TLPH, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$0$0$0$0$1K$0$27K$0
Cost of revenue$0$0$0$0$0$0$0$0
Gross profit$0$0$0$0$1K$0$27K$0
Selling, general and administrative$1.95M$2.23M$2.3M$1.89M$1.62M$2.19M$1.77M$1.67M
Research and development$2.19M$1.69M$1.65M$1.56M$1.8M$1.5M$1.17M$1.32M
Total operating expenses$4.14M$3.92M$3.95M$3.45M$3.42M$3.69M$2.94M$3M
Operating income-$4.14M-$3.92M-$3.95M-$3.45M-$3.42M-$3.69M-$2.92M-$3M
Interest expense$0$0$0$0$0$0$0$0
Income before taxes-$4.02M-$4.31M-$2.56M-$3.77M-$4.44M-$3.49M-$2.67M-$2.26M
Income taxes$0$0$0$0$0$0$0$0
Net income-$4.02M-$4.31M-$2.56M-$3.77M-$4.44M-$3.49M-$2.59M-$2.26M
Net income attributable to common shareholders-$4.02M-$4.31M-$2.56M-$3.77M-$4.44M-$3.49M-$2.59M-$1.87M
EBITDA-$4.14M-$3.92M-$3.95M-$3.45M-$3.42M-$3.69M-$2.92M-$3M
Basic earnings per share-$0.05-$0.06-$0.04-$0.06-$0.11-$0.10-$0.10-$0.07
Diluted earnings per share-$0.05-$0.06-$0.04-$0.06-$0.11-$0.10-$0.10-$0.07

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

ALPHEA Secures $5M Strategic Funding

ALPHEA, a platform building infrastructure for AI agents, has secured $5 million in strategic funding from investors including MH Ventures, IBC Ventures, Titan Ventures, and Becker Ventures. The funding will accelerate product development and expand ALPHEA's global node ecosystem, enabling AI agents to run, collaborate, store data, and settle value efficiently in a distributed cloud environment designed specifically for autonomous AI operations.

GlobeNewswire Inc.

ALPHEA Secures $5M Strategic Funding

ALPHEA, an AI infrastructure platform, has raised $5 million in strategic funding from investors including MH Ventures, IBC Ventures, Titan Ventures, and Becker Ventures. The funding will accelerate development of ALPHEA's AI-native distributed cloud designed specifically for autonomous agents, with plans to expand its global node ecosystem and improve developer tools.

Benzinga

Why Sintx Technologies Shares Are Trading Higher By Over 39%; Here Are 20 Stocks Moving Premarket

Shares of Sintx Technologies, Inc. (NASDAQ: SINT) rose sharply in today’s pre-market trading after the company announced its subsidiary Technology Assessment & Transfer entered into a Cooperative Research and Development agreement with the U.S. Army Combat Capabilities Development Command Army Research Laboratory. Sintx Technologies shares jumped 39.3% to $0.3393 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) gained 50.3% to $11.95 in pre-market trading after dipping around 39% on Tuesday. Minim, Inc. (NASDAQ: MINM) shares jumped 31.1% to $3.33 in pre-market trading. David E. Lazar disclosed a 51% active stake in Minim Inc. Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) surged 25.5% to $0.1010 in pre-market trading after falling around 7% on Tuesday. Paramount Global (NASDAQ: PARA) gained 20.6% to $16.50 in pre-market trading. Byron Allen offered $14.3 billion to buy all of the outstanding shares of Paramount Global, Bloomberg reported. Pop Culture Group Co., Ltd (NASDAQ:

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.